Free Trial

Alto Neuroscience (ANRO) Insider Trading & Ownership

Alto Neuroscience logo
$4.31 +0.22 (+5.38%)
(As of 11/22/2024 ET)

Alto Neuroscience (NYSE:ANRO) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$9.85 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get ANRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ANRO Insider Buying and Selling by Quarter

Alto Neuroscience Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/9/2024Adam SavitzInsiderBuy12,069$12.60$152,069.40  
3/28/2024Nicholas Conrad SmithCFOBuy6,150$16.36$100,614.00  
2/6/2024Wave Global Lp AlphaMajor ShareholderBuy600,000$16.00$9,600,000.00  
(Data available from 1/1/2013 forward)

ANRO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Alto Neuroscience includes Adam Savitz, Nicholas Conrad Smith, and Wave Global Lp Alpha. Learn more on insiders at ANRO.

The following insiders have purchased ANRO shares in the last 24 months: Adam Savitz ($152,069.40), Nicholas Conrad Smith ($100,614.00), and Wave Global Lp Alpha ($9,600,000.00).

Insiders have purchased a total of 618,219 ANRO shares in the last 24 months for a total of $9,852,683.40 bought.

Alto Neuroscience Key Executives

  • Dr. Amit Etkin M.D. (Age 47)
    Ph.D., Founder, Chairman of the Board, CEO & President
    Compensation: $705.65k
  • Mr. Nicholas C. Smith (Age 35)
    CFO & Secretary
    Compensation: $624.12k
  • Mr. Adam Savitz M.D. (Age 58)
    Ph.D., Chief Medical Officer
    Compensation: $579.57k
    1 recent trades
  • Ms. Melissa Berman (Age 44)
    Vice President of Finance & Accounting
  • Ms. Erin R. McQuade J.D. (Age 49)
    General Counsel & Chief Administrative Officer
  • Ms. Jessica Powell (Age 49)
    Chief Development Officer
  • Mr. Fadi Abdel M.D. (Age 45)
    Senior Vice President of Innovation


This page (NYSE:ANRO) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners